Report Detail

Request for Sample of this report

Service & Software Global Next-Generation Tumor Genetic Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4680112
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Next-Generation Tumor Genetic Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Next-Generation Tumor Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next-Generation Tumor Genetic Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Next-Generation Tumor Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Next-Generation Tumor Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Next-Generation Tumor Genetic Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Tumor Genetic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Tumor Genetic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Next-Generation Tumor Genetic Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Market segment by players, this report covers
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Next-Generation Tumor Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Tumor Genetic Testing, with revenue, gross margin, and global market share of Next-Generation Tumor Genetic Testing from 2021 to 2026.
Chapter 3, the Next-Generation Tumor Genetic Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Next-Generation Tumor Genetic Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Tumor Genetic Testing.
Chapter 13, to describe Next-Generation Tumor Genetic Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Next-Generation Tumor Genetic Testing by Type
    • 1.3.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Fluorescence In Situ Hybridization
    • 1.3.4 Polymerase Chain Reaction
    • 1.3.5 Microarray Technology
    • 1.3.6 Serum Proteomics
    • 1.3.7 Nucleic Acid Sequencing
  • 1.4 Global Next-Generation Tumor Genetic Testing Market by Application
    • 1.4.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Speciality Clinics
    • 1.4.4 Research Institutes
    • 1.4.5 Diagnostics Laboratories
    • 1.4.6 Biopharmaceutical Companies
  • 1.5 Global Next-Generation Tumor Genetic Testing Market Size & Forecast
  • 1.6 Global Next-Generation Tumor Genetic Testing Market Size and Forecast by Region
    • 1.6.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Next-Generation Tumor Genetic Testing Market Size by Region, (2021-2032)
    • 1.6.3 North America Next-Generation Tumor Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Next-Generation Tumor Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Next-Generation Tumor Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Devyser
    • 2.1.1 Devyser Details
    • 2.1.2 Devyser Major Business
    • 2.1.3 Devyser Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.1.4 Devyser Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Devyser Recent Developments and Future Plans
  • 2.2 Agendia
    • 2.2.1 Agendia Details
    • 2.2.2 Agendia Major Business
    • 2.2.3 Agendia Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.2.4 Agendia Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Agendia Recent Developments and Future Plans
  • 2.3 Illumina
    • 2.3.1 Illumina Details
    • 2.3.2 Illumina Major Business
    • 2.3.3 Illumina Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.3.4 Illumina Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Illumina Recent Developments and Future Plans
  • 2.4 Personal Genome Diagnostics
    • 2.4.1 Personal Genome Diagnostics Details
    • 2.4.2 Personal Genome Diagnostics Major Business
    • 2.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.4.4 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
  • 2.5 Veracyte
    • 2.5.1 Veracyte Details
    • 2.5.2 Veracyte Major Business
    • 2.5.3 Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.5.4 Veracyte Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Veracyte Recent Developments and Future Plans
  • 2.6 Pacific Biosciences of California
    • 2.6.1 Pacific Biosciences of California Details
    • 2.6.2 Pacific Biosciences of California Major Business
    • 2.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.6.4 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
  • 2.7 Qiagen
    • 2.7.1 Qiagen Details
    • 2.7.2 Qiagen Major Business
    • 2.7.3 Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.7.4 Qiagen Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Qiagen Recent Developments and Future Plans
  • 2.8 Agilent Technologies
    • 2.8.1 Agilent Technologies Details
    • 2.8.2 Agilent Technologies Major Business
    • 2.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.8.4 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Agilent Technologies Recent Developments and Future Plans
  • 2.9 Natera
    • 2.9.1 Natera Details
    • 2.9.2 Natera Major Business
    • 2.9.3 Natera Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.9.4 Natera Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Natera Recent Developments and Future Plans
  • 2.10 Bio Rad Laboratories
    • 2.10.1 Bio Rad Laboratories Details
    • 2.10.2 Bio Rad Laboratories Major Business
    • 2.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.10.4 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
  • 2.11 Myriad Genetics
    • 2.11.1 Myriad Genetics Details
    • 2.11.2 Myriad Genetics Major Business
    • 2.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
    • 2.11.4 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Myriad Genetics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Next-Generation Tumor Genetic Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Next-Generation Tumor Genetic Testing by Company Revenue
    • 3.2.2 Top 3 Next-Generation Tumor Genetic Testing Players Market Share in 2025
    • 3.2.3 Top 6 Next-Generation Tumor Genetic Testing Players Market Share in 2025
  • 3.3 Next-Generation Tumor Genetic Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Next-Generation Tumor Genetic Testing Market: Region Footprint
    • 3.3.2 Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
    • 3.3.3 Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Next-Generation Tumor Genetic Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Next-Generation Tumor Genetic Testing Market Size by Application (2021-2032)
  • 6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country
    • 6.3.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country
    • 7.3.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region
    • 8.3.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Next-Generation Tumor Genetic Testing Market Size by Country
    • 9.3.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country
    • 10.3.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Next-Generation Tumor Genetic Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Next-Generation Tumor Genetic Testing Market Drivers
  • 11.2 Next-Generation Tumor Genetic Testing Market Restraints
  • 11.3 Next-Generation Tumor Genetic Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Next-Generation Tumor Genetic Testing Industry Chain
  • 12.2 Next-Generation Tumor Genetic Testing Upstream Analysis
  • 12.3 Next-Generation Tumor Genetic Testing Midstream Analysis
  • 12.4 Next-Generation Tumor Genetic Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Next-Generation Tumor Genetic Testing. Industry analysis & Market Report on Next-Generation Tumor Genetic Testing is a syndicated market report, published as Global Next-Generation Tumor Genetic Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Next-Generation Tumor Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo